108 related articles for article (PubMed ID: 9187523)
1. Pharmacology and pharmacokinetics of LEX 032, a bioengineered serpin: the first of a potential new class of drugs.
Sands H; Hook JB
Drug Metab Rev; 1997; 29(1-2):309-28. PubMed ID: 9187523
[No Abstract] [Full Text] [Related]
2. Biodistribution and pharmacokinetics of 131I-labeled LEX 032, a recombinant hybrid of antichymotrypsin.
Sands H; Li J; Duggaraju R; Kolan HR; Donegan M; Elove GA; Thakur ML
Drug Metab Dispos; 1997 May; 25(5):631-6. PubMed ID: 9152604
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neutrophil proteinases by recombinant serpin Lex032 reduces capillary no-reflow in ischemia/reperfusion-induced acute pancreatitis.
von Dobschuetz E; Hoffmann T; Messmer K
J Pharmacol Exp Ther; 1999 Aug; 290(2):782-8. PubMed ID: 10411592
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human leukocyte proteinase 3 by a novel recombinant serine proteinase inhibitor (LEX032).
Groutas WC; Ruan S; Kuang R; Hook JB; Sands H
Biochem Biophys Res Commun; 1997 Apr; 233(3):697-9. PubMed ID: 9168917
[TBL] [Abstract][Full Text] [Related]
5. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998
[TBL] [Abstract][Full Text] [Related]
6. The role of protease inhibition with emphasis on the effects of inflammation and vascular immune phenomena.
Bilfinger TV; Stefano GB
Curr Pharm Des; 2002; 8(7):505-9. PubMed ID: 11945155
[TBL] [Abstract][Full Text] [Related]
7. Serpins for diagnosis and therapy in cancer.
Zheng D; Chen H; Davids J; Bryant M; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury.
Murohara T; Guo JP; Lefer AM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1246-53. PubMed ID: 7562495
[TBL] [Abstract][Full Text] [Related]
9. Novel recombinant serpin, LEX-032, attenuates myocardial reperfusion injury in cats.
Delyani JA; Murohara T; Lefer AM
Am J Physiol; 1996 Mar; 270(3 Pt 2):H881-7. PubMed ID: 8780182
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of Manduca sexta serpin-6: a serine proteinase inhibitor that selectively inhibits prophenoloxidase-activating proteinase-3.
Wang Y; Jiang H
Insect Biochem Mol Biol; 2004 Apr; 34(4):387-95. PubMed ID: 15041022
[TBL] [Abstract][Full Text] [Related]
11. Anti-apoptotic serpins as therapeutics in cardiovascular diseases.
Kuiper J; Quax PH; Bot I
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):111-22. PubMed ID: 23987999
[TBL] [Abstract][Full Text] [Related]
12. The effects of a neutrophil elastase inhibitor (ONO-5046.Na) and neutrophil depletion using a granulotrap (G-1) column on lung reperfusion injury in dogs.
Tomizawa N; Ohwada S; Ohya T; Takeyoshi I; Ogawa T; Kawashima Y; Adachi M; Morishita Y
J Heart Lung Transplant; 1999 Jul; 18(7):637-45. PubMed ID: 10452339
[TBL] [Abstract][Full Text] [Related]
13. SerpinI2 (pancpin) is an inhibitory serpin targeting pancreatic elastase and chymotrypsin.
Higgins WJ; Grehan GT; Wynne KJ; Worrall DM
Biochim Biophys Acta Proteins Proteom; 2017 Feb; 1865(2):195-200. PubMed ID: 27989643
[TBL] [Abstract][Full Text] [Related]
14. A recombinant wheat serpin with inhibitory activity.
Rasmussen SK; Dahl SW; Norgård A; Hejgaard J
Plant Mol Biol; 1996 Feb; 30(3):673-7. PubMed ID: 8605317
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of LEX032, a novel recombinant serine protease inhibitor, in murine traumatic shock.
Scalia R; Gauthier TW; Lefer AM
Shock; 1995 Oct; 4(4):251-6. PubMed ID: 8564552
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of chymotrypsin- and subtilisin-like serine proteases with Tk-serpin from hyperthermophilic archaeon Thermococcus kodakaraensis.
Tanaka S; Koga Y; Takano K; Kanaya S
Biochim Biophys Acta; 2011 Feb; 1814(2):299-307. PubMed ID: 21112419
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of proteinase 3 activity by peptides derived from human epidermis.
Wiedow O; Lüdemann J; Utecht B; Christophers E
Adv Exp Med Biol; 1993; 336():61-4. PubMed ID: 8296675
[TBL] [Abstract][Full Text] [Related]
18. The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.
Lucas A; Liu L; Dai E; Bot I; Viswanathan K; Munuswamy-Ramunujam G; Davids JA; Bartee MY; Richardson J; Christov A; Wang H; Macaulay C; Poznansky M; Zhong R; Miller L; Biessen E; Richardson M; Sullivan C; Moyer R; Hatton M; Lomas DA; McFadden G
Adv Exp Med Biol; 2009; 666():132-56. PubMed ID: 20054981
[TBL] [Abstract][Full Text] [Related]
19. Serpins, the vasculature, and viral therapeutics.
Richardson J; Viswanathan K; Lucas A
Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
[TBL] [Abstract][Full Text] [Related]
20. Effects of LEX032, a novel recombinant serine protease inhibitor, on N(G)-nitro-L-arginine methyl ester induced leukocyte-endothelial cell interactions.
Bains AS; Scalia R; Lefer AM
Eur J Pharmacol; 1998 Aug; 356(1):67-72. PubMed ID: 9761425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
